Page last updated: 2024-12-05

2,6-dinitrotoluene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,6-dinitrotoluene: RN given refers to cpd with specified locants for nitrogen moieties [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,6-dinitrotoluene : A dinitrotoluene carrying nitro substituents at positions 2 and 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11813
CHEMBL ID1328508
CHEBI ID957
CHEBI ID63756
SCHEMBL ID472112
MeSH IDM0080862

Synonyms (52)

Synonym
unii-gg7fav92mk
gg7fav92mk ,
benzene, 2-methyl-1,3-dinitro-
toluene, 2,6-dinitro-
2-methyl-1,3-dinitrobenzene
SGCUT00101
CHEBI:957 ,
1-methyl-2,6-dinitrobenzene
2,6-dinitromethylbenzene
NCGC00091312-01
rcra waste no. u106
ccris 1006
hsdb 2931
einecs 210-106-0
brn 2052046
rcra waste number u106
2,6-dinitrotoluene
2,6-dnt
606-20-2
TO_000039
2,6-dinitrotoluene, 98%
D1151
NCGC00091312-02
inchi=1/c7h6n2o4/c1-5-6(8(10)11)3-2-4-7(5)9(12)13/h2-4h,1h
A832811
2-methyl-1,3-dinitro-benzene
AKOS005254581
NCGC00091312-04
NCGC00091312-03
tox21_201855
NCGC00254319-01
cas-606-20-2
NCGC00259404-01
dtxcid30528
tox21_300479
dtxsid5020528 ,
FT-0610717
CHEBI:63756 ,
EPITOPE ID:161173
2,6-dinitrotoluene [hsdb]
2,6-dinitrotoluene [iarc]
dinitrotoluene, 2,6-
SCHEMBL472112
CHEMBL1328508
mfcd00007158
F1091-0006
2,6-dinitrotoluene, analytical standard
benzene, 2-methyl-1,3-dinitro-; toluene, 2,6-dinitro- (8ci); 2-methyl-1,3-dinitrobenzene; 1-methyl-2,6-dinitrobenzene; 2,6-dnt; 2,6-dinitrotoluene
2,6-dinitrotoluene 10 microg/ml in acetonitrile
Q2286646
AS-12673
EN300-50206

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" TNT appeared to be more toxic than 2,4-DNT, which also showed a higher toxicity compared to 2,6-DNT."( Transcriptional activation of stress genes and cytotoxicity in human liver carcinoma cells (HepG2) exposed to 2,4,6-trinitrotoluene, 2,4-dinitrotoluene, and 2,6-dinitrotoluene.
Ishaque, AB; Schneider, J; Tchounwou, PB; Wilson, BA, 2001
)
0.51
" Clear signs of toxic nephropathy were found in rats dosed with DNT, and the concept was derived of an interrelation between renal toxicity and carcinogenicity."( Nephrotoxicity and nephrocarcinogenicity of dinitrotoluene: new aspects to be considered.
Bolt, HM; BrĂ¼ning, T; Thier, R,
)
0.13
" Results indicated that 2,6 DNT was more toxic to breast cells; LC50 values were 445 and 292 ppm at 24 and 48 hours respectively compared to 2,4 DNT showing LC50 values of 570 and 407 ppm at 24 and 48 hours, respectively."( Cytotoxicity of dinitrotoluenes (2,4-dNT, 2,6-DNT ) to MCF-7 and MRC-5 cells.
Ballard, FV; Boucaud, D; Dulal, K; Gerald, TM; Hupke, C; Ishaque, AB; Johnson, LR; Tchounwou, PB; Timmons, C, 2005
)
0.33
" In factory workers, exposure to DNTs has been linked to many adverse health effects, including: cyanosis, vertigo, headache, metallic taste, dyspnea, weakness and lassitude, loss of appetite, nausea, and vomiting."( Cytotoxicity and expression of c-fos, HSP70, and GADD45/153 proteins in human liver carcinoma (HepG2) cells exposed to dinitrotoluenes.
Glass, KY; Newsome, CR; Tchounwou, PB, 2005
)
0.33
" 2,6-DNT had toxic effects on the growth of Arabidopsis based on whole seedling as well as root growth assays."( Phytotoxicity and phytoremediation of 2,6-dinitrotoluene using a model plant, Arabidopsis thaliana.
Oliver, DJ; Shanks, JV; Yoon, JM, 2007
)
0.61
" To evaluate the possibility of adverse effects in birds, the effects from oral exposures of 2,6-dinitrotoluene (2,6-DNT) and 1,3,5-trinitro-1,3,5-triazine (RDX) were tested using a controlled dosing regime in northern bobwhite (Colinus virginianus)."( Subacute toxicity of oral 2,6-dinitrotoluene and 1,3,5-trinitro-1,3,5-triazine (RDX) exposure to the northern bobwhite (Colinus virginianus).
Bazar, MA; Escalon, BL; Gust, KA; Johnson, MS; Perkins, EJ; Quinn, MJ, 2007
)
0.86
" The goal of this study was to determine the acute toxic effects of TNT, 2,4-DNT, and 2,6-DNT in adult male bullfrogs."( Acute toxicity of 2,4,6-trinitrotoluene, 2,4-dinitrotoluene, and 2,6-dinitrotoluene in the adult bullfrog (Lithobates catesbeiana).
Kendall, RJ; Paden, NE; Smith, EE, 2008
)
0.58
" These key developmental processes include neural progenitor cell proliferation, neuronal and oligodendrocyte differentiation, neural cell migration, neurite outgrowth, synaptogenesis and neuronal network formation, as well key events identified in the existing Adverse Outcome Pathways (AOPs)."( The potential of mechanistic information organised within the AOP framework to increase regulatory uptake of the developmental neurotoxicity (DNT) in vitro battery of assays.
Bal-Price, A; Pistollato, F; Sachana, M; Willett, C, 2021
)
0.62

Bioavailability

ExcerptReferenceRelevance
" Tests were conducted in Sassafras sandy loam soil, which supports relatively high bioavailability of nitroaromatic EMs."( Toxicities of dinitrotoluenes and trinitrobenzene freshly amended or weathered and aged in a sandy loam soil to Enchytraeus crypticus.
Checkai, RT; Kolakowski, JE; Kuperman, RG; Kurnas, CW; Phillips, CT; Simini, M, 2006
)
0.33

Dosage Studied

The onset of seizures resulting in death was observed in the avian model Northern bobwhite after oral dosing with RDX beginning at 8 mg/kg/day in subacute (14 days) exposures. Affective doses of the TNT derivative, 2,6-dinitrotoluene (2,4-DNT), caused gastrointestinal impacts, lethargy, and emaciation.

ExcerptRelevanceReference
" Unchanged 2,6-dinitrotoluene (2,6-DNT), 2-amino-6-nitrotoluene, 2,6-dinitrobenzyl alcohol, 2-amino-6-nitrobenzyl alcohol, conjugated 2,6-dinitrobenzyl alcohol and conjugated 2-amino-6-nitrobenzyl alcohol were detected in urine of male Wistar rats dosed with 2,6-DNT."( Metabolism of 2,6-dinitrotoluene in male Wistar rat.
Kawajiri, T; Kozuka, H; Miyahara, T; Mori, M; Sayama, M; Taniuchi, Y, 1989
)
1.03
" Conjugates of 2,4-dinitrobenzyl alcohol (2,4-DNB) and 2,6-dinitrobenzyl alcohol (2,6-DNB), which were major urinary metabolites of the male Wistar rat dosed orally with 2,4-dinitrotoluene (2,4-DNT) or 2,6-dinitrotoluene (2,6-DNT), were examined by hplc using potassium 2,4-dinitrobenzyl glucuronide (2,4-DNB-G), potassium 2,6-dinitrobenzyl glucuronide (2,6-DNB-G), pyridinium 2,4-dinitrobenzyl sulphate (2,4-DNB-S), and pyridinium 2,6-dinitrobenzyl sulphate (2,6-DNB-S) as authentic compounds."( Further studies on the urinary metabolites of 2,4-dinitrotoluene and 2,6-dinitrotoluene in the male Wistar rat.
Dohrin, M; Honda, T; Kawagoshi, T; Kozuka, H; Mori, MA; Shoji, M, 1996
)
0.72
" Major biliary conjugates of the male Wistar rat dosed orally with 2,4-dinitrotoluene (2,4-DNT) or 2,6-dinitrotoluene (2,6-DNT) were examined by hplc using potassium 2,4-dinitrobenzyl glucuronide (potassium 2,4-DNB-G), potassium 2,6-dinitrobenzyl glucuronide (potassium 2,6-DNB-G), pyridinium 2,4-dinitrobenzyl sulphate (pyridinium 2,4-DNB-S) and pyridinium 2,6-dinitrobenzyl sulphate (pyridinium 2,6-DNB-S) as authentic compounds."( Biliary excretion and microfloral transformation of major conjugated metabolites of 2,4-dinitrotoluene and 2,6-dinitrotoluene in the male Wistar rat.
Honda, T; Inoue, M; Kawagoshi, T; Maeda, M; Mori, MA; Sayama, M; Shoji, M, 1997
)
0.73
" Clear signs of toxic nephropathy were found in rats dosed with DNT, and the concept was derived of an interrelation between renal toxicity and carcinogenicity."( Nephrotoxicity and nephrocarcinogenicity of dinitrotoluene: new aspects to be considered.
Bolt, HM; BrĂ¼ning, T; Thier, R,
)
0.13
" To evaluate the possibility of adverse effects in birds, the effects from oral exposures of 2,6-dinitrotoluene (2,6-DNT) and 1,3,5-trinitro-1,3,5-triazine (RDX) were tested using a controlled dosing regime in northern bobwhite (Colinus virginianus)."( Subacute toxicity of oral 2,6-dinitrotoluene and 1,3,5-trinitro-1,3,5-triazine (RDX) exposure to the northern bobwhite (Colinus virginianus).
Bazar, MA; Escalon, BL; Gust, KA; Johnson, MS; Perkins, EJ; Quinn, MJ, 2007
)
0.86
" The electrolytic experiments were carried out to elucidate the influence of various operating parameters on the performance of mineralization of total organic compounds (TOC) in spent acid, including electrode potential, reaction temperature, oxygen dosage and concentration of sulfuric acid."( Electrochemical destruction of dinitrotoluene isomers and 2,4,6-trinitrotoluene in spent acid from toluene nitration process.
Chen, WS; Liang, JS, 2009
)
0.35
" The onset of seizures resulting in death was observed in the avian model Northern bobwhite after oral dosing with RDX beginning at 8 mg/kg/day in subacute (14 days) exposures, whereas affective doses of the TNT derivative, 2,6-dinitrotoluene (2,6-DNT), caused gastrointestinal impacts, lethargy, and emaciation in subacute and subchronic (60 days) exposures."( Neurotoxicogenomic investigations to assess mechanisms of action of the munitions constituents RDX and 2,6-DNT in Northern bobwhite (Colinus virginianus).
Clarke, J; Deng, Y; Escalon, L; Gong, P; Guan, X; Gust, KA; Indest, KJ; Johnson, MS; Perkins, EJ; Pirooznia, M; Quinn, MJ, 2009
)
0.54
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
genotoxinA role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dinitrotolueneAny nitrotoluene carrying two nitro substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
2,6-dinitrotoluene degradation011

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency10.00000.004023.8416100.0000AID485290
acetylcholinesteraseHomo sapiens (human)Potency41.86020.002541.796015,848.9004AID1347395
progesterone receptorHomo sapiens (human)Potency76.95880.000417.946075.1148AID1346795
estrogen nuclear receptor alphaHomo sapiens (human)Potency22.16140.000229.305416,493.5996AID743069; AID743075
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency27.30600.000323.4451159.6830AID743066
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (121)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (19.83)18.7374
1990's26 (21.49)18.2507
2000's46 (38.02)29.6817
2010's23 (19.01)24.3611
2020's2 (1.65)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index33.16 (24.57)
Research Supply Index4.87 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index44.00 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (33.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (3.10%)6.00%
Case Studies2 (1.55%)4.05%
Observational0 (0.00%)0.25%
Other123 (95.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]